Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1131-1137

  Toi, Masakazu ^a   Ueno, Takayuki ^a   Matsumoto, Hiroshi ^a   Saji, Hisashi ^a   Funata, Nobuaki ^a   Koike, Morio ^a   Tominaga, Takeshi ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Tokyo Metropolitan Komagome Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD68 ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; THYMIDINE PHOSPHORYLASE; TUMOR MARKER;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER SIZE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE TABLES; MASTECTOMY; MIDDLE AGED; MONOCYTES; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STROMAL CELLS; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0032933732     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Mantovani, A. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest., 71: 5-16, 1994.
2. Graves, D. T., and Valente, A. J. Monocyte chemotactic proteins from human tumor cells. Biochem. Pharmacol., 41: 333-337, 1991.
3. Oppenheim, J. J., Zachariae, C. O., Mukaida, N., and Matsushima, K. Properties of the novel proinflammatory supergene intercrine cytokine family. Annu. Rev. Immunol., 9: 617-621, 1991.
4. Polverini, P. J. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur. J. Cancer, 32A: 2430-2437, 1996.
5. O'Sullivan, C., Lewis, C. E., Harris, A. L., and McGee, J. O. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet, 42: 148-149, 1993.
6. Falcone, D. J., McCaffrey, T. M., Haimovitz-Friedman, A., and Garcia, M. Transforming growth factor-1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell. Physiol., 755: 595-605, 1993.
7. Roger, P., Montcourrier, P., Maudelonde, T., Brouillet, J. P., Pages, A., Laffargue, F., and Rochefort, H. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages. Hum. Pathol., 25: 863-871, 1994.
8. Heppner, K. J., Matrisian, L. M., Jensen, R. A., and Rodgers, W. H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol., 149: 273-282, 1996.
9. Hildenbrand, R., Dilger, I., Horlin, A., and Stutte, H. J. Urokinase and macrophages in tumor angiogenesis. Br. J. Cancer, 72: 818-823, 1995.
10. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., and Harris, A. L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res., 56: 4625-4629, 1996.
11. Evans, R. Effect of X-irradiation on host cell infiltration and growth of murine fibrosarcoma. Br. J. Cancer, 35: 557-566, 1977.
12. Pupa, S. M., Bufalino, R., Invernizzi, A. M., Andreola, S., Rilke, F., Lombardi, L., Colnaghi, M. I., and Menard, S. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J. Clin. Oncol., 14: 85-94, 1996.
13. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K. C., and Harris, A. L. Loss of transporter in antigen processing 1 transport protein and major histocompatibility breast cancer. Cancer Res., 55: 5191-5194, 1995.
14. Folkman, J. What is the role of thymidine phosphorylase in tumor angiogenesis. J. Natl. Cancer Inst. (Bethesda), 88: 1091-1092, 1996.
15. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1989.
16. Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., and Akiyama, S. Angiogenic factor. Nature (Lond.), 356: 668, 1992.
17. Moghaddam, A., Zhang, H. T., Fan, T. P. D., Hu, D. E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA. 92: 998-1002, 1995.
18. Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. Expression of platelet-derived endothelial cell growth factor in human breast cancer. Int. J. Cancer, 64: 79-82, 1995.
19. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Differential angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
20. Reynolds, K., Farzaneh, F., Collins, W. P., Campbell, S., Bourne, T. H., Lawton, F., Moghaddam, A., Harris, A. L., and Bicknell, R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst. (Bethesda), 86: 1234-1238, 1994.
21. Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A., Tanaka, Y., Wada, K., and Ishitsuka, H. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chem. Pharmacol., 32: 333-338, 1993.
22. Griffiths, L., Dachs, G. U., Bicknell, R., Harris, A. L., and Stratford, I. J. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res., 57: 570-572, 1997.
23. Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., Bicknell, R., Gatter, K. C., and Harris, A. L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer, 73: 275-280, 1996.
24. Toi, M., Taniguchi, T., Yamamoto, Y., Kurisaki, T., Suzuki, H., and Tominaga, T. Clinical significance of the determination of angiogenic factors. Eur. J Cancer, 32: 2513-2519, 1996.
25. Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., Onoda, N., Kato, Y., and Sowa, M. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br. J. Cancer, 73: 884-888, 1996.
26. Takebayashi, Y., Akiyama, S., Akiba, S., Yamada, K., Miyadera, K., Sumizawa, T., Yamada, Y., Murata, F., and Aikou, T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst. (Bethesda), 88: 1110-1117, 1996.
27. Jin, L., Yuan, R. Q., Fuchs, A., Yao, Y., Joseph, A., Schnitt, S. J., Guida, A., Hastings, H. M., Andres, J., Turkel, G., Polverini, P. J., Goldberg, I. D., and Rosen, E. M. Expression of interleukin-1 in human breast carcinoma. Cancer (Phila.), 80: 421-434, 1997.
28. Dayer, J. M., Beutler, B., and Cerami, A. Cachetin tumor necrosis factor stimulates collagenase and prostaglandin E-2 production by human synovial cells and dermal fibroblasts. J. Exp. Med., 162: 2163-2168, 1985.
29. Dayer, J. M., Rochemonteix, B. De., Burrus, B., Demczuk, S., and Dinarello, C. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E-2 production by human synovial cells. J. Clin. Invest., 77: 645-648, 1986.
30. Sciavolino, P. J., Lee, T. H., and Vilcek, J. Interferon-β induces metalloproteinase mRNA expression in human fibroblasts. J. Biol. Chem., 269; 21627-21634, 1994.
31. Stetler-Stevenson, W. G., Liotta, L. A., and Brown, P. D. Role of type-IV collagenases in human breast cancer. In: R. B. Dickson and M. E. Lippman (eds.), Genes, Oncogenes, and Hormones: Advancements in Cellular and Molecular Biology of Breast Cancer, pp. 21-41. Boston: Kluwer Academic Publishers, 1991.
32. Ferrara, N. Vascular endothelial growth factor. Eur. J. Cancer, 32A: 2413-2422, 1996.
33. Kuwabara, K., Ogawa, S., Matsumoto, M., Koga, S., Clauss, M., Pinsky, D., Lyn, P., Leavy, J., Witte, L., Joseph-Silverstein, J., Furie, M., Torcia, G., Cozzolino, F., Kamada, K., and Stern, D. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxia endothelial cells. Proc. Natl. Acad. Sci. USA, 92: 4606-4610, 1995.
34. Toi, M., Inada, K., Hoshina, S., Suzuki, H., Kondo, S., and Tominaga T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin. Cancer Res., 1: 961-964, 1995.
35. Toi, M., Gion, M., Biganzoli, E., Dittadi, R., Boracchi, P., Miceli, R., Meli, S., Mori, K., Tominaga, T., and Gasparini, G. Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications. Angiogenesis, 1: 71-83, 1997.
36. Dong, Z., Kumar, R., Yang, X., and Fidler, I. J. Macrophage-derived metaloerastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88: 801-810, 1997.
37. Nagaoka, H., Iino, Y., Takei, H., and Morishita, Y. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer. Int. J. Oncol., 13: 449-454, 1998.
38. Vukanovic, J., and Isaacs, J. T. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res., 55: 1499-1504, 1995.
39. Ishitsuka, H., Miwa, M., Takemoto, K., Fukuoka, K., Itoga, A., and Maruyama, H. B. Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Jpn. J. Cancer Res., 71: 112-123, 1980.
40. Haraguchi, M., Furukawa, T., Sumizawa, T., and Akiyama, S. Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res., 53: 5680-5682, 1993.
41. Fox, S. B., Engels, K., Comley, M., Whitehouse, R. M., Turley, H., Gatter, K. C., and Harris, A. L. Relationship of elevated tumor thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol., 8: 271-275, 1997.